Cite Filings / AVTX / 0000899140-23-000400
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G/A

Amended Statement of Ownership

Avalo Therapeutics, Inc. · Filed 2023-02-14 · Acc 0000899140-23-000400

Documents 1

  • SC 13G/A Amended Statement of Ownership , pt7213ga.htm

Around this filing

  • 2023-02-15 4 Options or other derivatives
  • 2023-02-15 4 Options or other derivatives
  • 2023-02-14 SC 13G/A Amended Statement of Ownership
  • 2023-02-14 SC 13G/A Amended Statement of Ownership
  • 2023-02-14 SC 13G/A Amended Statement of Ownership
  • 2023-02-13 SC 13G Amended Statement of Ownership
  • 2022-08-08 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · BVF PARTNERS L P/IL 1.7%
  2. 2026-11-16 SCHEDULE 13G/A · Point72 Asset Management, L.P. 3.0%
  3. 2026-11-13 SCHEDULE 13G · Farallon Capital Management, L.L.C. 7.4%
Loading pt7213ga.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…